NCT03543215View on ClinicalTrials.gov

Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 13, 2017

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2025

Conditions
Endometrial CancerEndometrial Neoplasms
Interventions
OTHER

Radiomics: Analysis of textural features of imaging (MRI and Ultrasound)

All patients with confirmed endometrial cancer will have received Ultrasound and MRI as part of routine standard of care. Textural features from this will be analysed to see if can predict prognosis.

Trial Locations (1)

W12 0HS

RECRUITING

Queen Charlotte and Hammersmith Hospital, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT03543215 - Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | Biotech Hunter | Biotech Hunter